Article
A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML.
Neoplasia (New York, N.Y.) - 1 Mar 2021
Heimbruch Katelyn E, Meyer Alison E, Agrawal Puja, Viny Aaron D, Rao Sridhar
Abstract excerpt
Acute myeloid leukemia (AML) affects tens of thousands of patients a year, yet survival rates are as low as 25% in certain populations. This poor survival rate is partially due to the vast genetic diversity of the disease. Rarely do 2 patients with AML have the same mutational profile, which makes the development of targeted therapies particularly challenging. However, a set of recurrent mutations in chromatin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
